Expertise in all things FDA
Menu
Expertise in all things FDA
Overview
Charles G. Raver assists clients across a range of FDA-related regulatory matters by providing timely strategic advice on new drug and biologic development and helping them tackle complex regulatory issues. His practice supports clients throughout the life sciences from biotech startups and multinational pharmaceutical companies to CROs and academic researchers to patient advocacy organizations. Mr. Raver joined Hyman, Phelps & McNamara after more than a decade in biomedical research spent studying the neurobiological mechanisms of chronic pain and sensory processing. He now leverages his deep knowledge of the drug development ecosystem and background in neuroscience, pre-clinical animal research and study design to help clients navigate the regulatory landscape faced by the life sciences industry.
Mr. Raver graduated with honors from the University of Maryland Carey School of Law. While in law school, Mr. Raver served as a staff editor and the first social media chair for the Journal of Health Care Law & Policy. He also received two CALI awards after nabbing the top grade in courses on Animal Law and Written and Oral Advocacy. Throughout law school, Mr. Raver continued his neurobiology research career full-time. His research has resulted in nine original peer-reviewed research publications demonstrating potential therapeutic targets for treating chronic pain and revealing functions of neural circuits responsible for sensory processing. Mr. Raver also has extensive knowledge and direct experience with the advanced techniques driving development of current biomedical therapies, such as optogenetics, chemogenetics, viral vector-mediated gene delivery, and targeted stimulation techniques